AVERITAS Trademark

Trademark Overview

On Thursday, December 15, 2022, a trademark application was filed for AVERITAS with the United States Patent and Trademark Office. The USPTO has given the AVERITAS trademark a serial number of 97719971. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, June 4, 2025. This trademark is owned by Averitas Pharma, Inc.. The AVERITAS trademark is filed in the Education & Entertainment Services category with the following description:

Conducting of training courses in the field of medicine and pharmaceuticals; publishing and issuing of books, journals and scientific papers in the field of medicine and pharmaceuticals, especially for pharmaceutical companies, pharmacists, physicians, patients, health insurance companies and their professional associations; Providing online, non-downloadable educational videos in the fields of pain treatment and disease management; Providing educational materials in the fields of pain treatment and disease management in the nature of patient resource guides and self-help guides
averitas

General Information

Serial Number97719971
Word MarkAVERITAS
Filing DateThursday, December 15, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, June 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2023

Trademark Statements

Goods and ServicesConducting of training courses in the field of medicine and pharmaceuticals; publishing and issuing of books, journals and scientific papers in the field of medicine and pharmaceuticals, especially for pharmaceutical companies, pharmacists, physicians, patients, health insurance companies and their professional associations; Providing online, non-downloadable educational videos in the fields of pain treatment and disease management; Providing educational materials in the fields of pain treatment and disease management in the nature of patient resource guides and self-help guides

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, February 21, 2023
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAveritas Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960
Party NameAveritas Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960

Trademark Events

Event DateEvent Description
Monday, December 19, 2022NEW APPLICATION ENTERED
Thursday, January 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 14, 2023ASSIGNED TO EXAMINER
Tuesday, February 21, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 21, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, February 21, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 21, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, February 21, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 23, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 20, 2023SOU TEAS EXTENSION RECEIVED
Thursday, May 2, 2024SOU TEAS EXTENSION RECEIVED
Thursday, May 2, 2024SOU EXTENSION 2 GRANTED
Monday, November 20, 2023SOU EXTENSION 1 FILED
Monday, November 20, 2023SOU EXTENSION 1 GRANTED
Wednesday, November 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 2, 2024SOU EXTENSION 3 FILED
Thursday, May 2, 2024DIVISIONAL REQUEST RECEIVED
Thursday, May 2, 2024SOU EXTENSION 2 FILED
Thursday, May 2, 2024TEAS REQUEST TO DIVIDE RECEIVED
Friday, May 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 8, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 4, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 10, 2024ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Wednesday, August 7, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 8, 2024ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Thursday, September 5, 2024SOU EXTENSION 3 GRANTED
Thursday, September 5, 2024DIVISIONAL PROCESSING COMPLETE
Thursday, September 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 5, 2024CORRECTED NOA E-MAILED
Monday, May 19, 2025SOU EXTENSION 4 FILED
Tuesday, May 20, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, June 4, 2025SOU EXTENSION 4 GRANTED

Related Keywords

averitas educational pain treatment fields management guides pharmaceuticals providing companies field